Cargando…

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis

The recognition that drug-resistant tuberculosis (DR-TB) poses a major threat to global tuberculosis (TB) control efforts has catalysed the development of new and urgently needed TB diagnostics. The full beneficial impact of the subsequent flood of new TB diagnostic tests into the market can only be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nandlal, Louansha, Perumal, Rubeshan, Naidoo, Kogieleum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438776/ https://www.ncbi.nlm.nih.gov/pubmed/36060232 http://dx.doi.org/10.2147/IDR.S381643

Ejemplares similares

Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
por: Lale Ngema, Senamile, et al.
Publicado: (2023)

Advances in tuberculosis control during the past decade
por: Naidoo, Kogieleum, et al.
Publicado: (2023)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2014)

Long COVID: An approach to clinical assessment and management in primary care
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Higher plasma interleukin − 6 levels are associated with lung cavitation in drug-resistant tuberculosis
por: Maseko, Thando Glory, et al.
Publicado: (2023)

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
por: Dookie, Navisha, et al.
Publicado: (2018)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis [Corrigendum]
Publicado: (2022)

Nephrotic Syndrome in South African Children: Changing Perspectives in the New Millennium
por: Nandlal, Louansha, et al.
Publicado: (2019)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
por: Naidoo, Anushka, et al.
Publicado: (2022)

Biological mechanisms underpinning the development of long COVID
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
por: Dookie, Navisha, et al.
Publicado: (2022)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Rapid molecular assays for detection of tuberculosis
por: Eddabra, Rkia, et al.
Publicado: (2018)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance
por: Kirwan, Daniela E., et al.
Publicado: (2016)

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
por: Naicker, Nikita, et al.
Publicado: (2023)

Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial
por: Ross, Jesse E, et al.
Publicado: (2023)

Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial
por: Ross, Jesse, et al.
Publicado: (2023)

The Effect of miRNA Gene Regulation on HIV Disease
por: Chinniah, Romona, et al.
Publicado: (2022)

Improving survival with tuberculosis & HIV treatment integration: A mini-review
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing
por: Dookie, Navisha, et al.
Publicado: (2020)

Combination of commercially available molecular assays and culture based methods in diagnosis of tuberculosis and drug resistant tuberculosis
por: Gkaravela, Lamprini, et al.
Publicado: (2017)

Long COVID: a review and proposed visualization of the complexity of long COVID
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients
por: Gordhan, Bhavna G., et al.
Publicado: (2022)

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies
por: Manyana, Sontaga, et al.
Publicado: (2021)

Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis
por: Bhagwan, Smita, et al.
Publicado: (2011)

NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity
por: Maseko, Thando Glory, et al.
Publicado: (2023)

The whole is greater than the sum of the parts: Recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2009)

Prevalence of Primary Hypertension and Risk Factors in Grade XII Learners in KwaZulu-Natal, South Africa
por: Bhimma, Rajendra, et al.
Publicado: (2018)

The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
por: Hariparshad, Sudesh, et al.
Publicado: (2023)

Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB(®) Assay
por: Ok, Vichita, et al.
Publicado: (2021)

Multiple microbiologic tests for tuberculosis improve diagnostic yield of bronchoscopy in medically complex patients
por: Fakey Khan, Dilshaad, et al.
Publicado: (2019)

Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
por: Makamure, Beauty, et al.
Publicado: (2013)

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests
por: Naidoo, Pren, et al.
Publicado: (2015)

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis
por: Catanzaro, Antonino, et al.
Publicado: (2015)

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
por: Georghiou, Sophia B., et al.
Publicado: (2016)

Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
por: Nguyen, Thi Ngoc Anh, et al.
Publicado: (2019)

Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study
por: O'Riordan, Philly, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2obiapmjmr68eu0s32bb166459